PPT-Abuse Deterrent Opioids
Author : marina-yarberry | Published Date : 2018-10-24
a Law enforcement perspective Charlie Cichon Executive Director The National Association of Drug Diversion Investigators NADDI The National Association of Drug Diversion
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Abuse Deterrent Opioids" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Abuse Deterrent Opioids: Transcript
a Law enforcement perspective Charlie Cichon Executive Director The National Association of Drug Diversion Investigators NADDI The National Association of Drug Diversion Investigators or NADDI is a nonprofit membership organization that works to develop and implement solutions to the problem of prescription drug diversion . Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Presentation provided by. Meldon. . Kahan. , MD. Family & Community Medicine. University of . T. oronto. CSAM-SCAM Fundamentals. Conflict of interest statement. Dr. Christy Sutherland . -. none. . Melissa B. Weimer, DO, MCR. Disclosures. Dr. Weimer is a consultant for . INFORMed. , IMPACT education, and the American Association of Addiction Psychiatry.. Dr. Weimer is the medical director of CODA, Inc. . Bob Sammons, M.D., Ph.D.. Mesa Behavioral Medicine Clinic. TMS Solutions. Conflict of interest. None. Dr. Sammons received a bachelors and master’s degree from Auburn University, a PhD in clinical psychology from the University of North Carolina at Greensboro, and a medical degree from the University of North Carolina at Chapel Hill. He did a residency in psychiatry at the University of Virginia as well as a forensic fellowship. While serving in the United States Air Force as a squad commander and captain, he was selected as one of 5 psychologist to establish the opiate treatment phase of the drug treatment program for the Department of Air Force in 1972. For this he receive the Meritorious Service Medal. He has practiced adult psychiatry in Grand Junction for 28 years. He is 1 of 2 physicians in town that have received specialist training and a special DEA number that allows him to prescribe Suboxone treatment for opiate dependency.. Wayne Winegarden, Ph.D.. Sr. Fellow, Business & Economics, Pacific Research Institute. Contributing Editor, EconoSTATS a project of George Mason University. Partner, Capitol Economic Advisors. Presentation CWAG Annual Conference. challenges, risks, and negotiations. Mark Sullivan, MD, PhD. University of Washington. Psychiatry and Behavioral Sciences. Anesthesiology and Pain Medicine. Bioethics and Humanities. CME grant from REMS-RPC to disseminate COPE-REMS training. The Epidemic. Chronic Pain and Prescription Opioids. 11% of Americans experience daily (chronic) pain. Opioids frequently prescribed for chronic pain. Primary care providers commonly treat chronic, non-cancer pain. Stimulants: . Opinions . of the Medical . Expert Panel regarding Commercial Driver Performance and Crash Risk. Presenter: . Mitchell A. . Garber,. MD, MPH, MSME, Senior Managing Consultant, Engineering Systems, Inc. . Saturday April 14, 2018. Kelly . Bossenbroek Fedoriw, MD. Opioid Crisis?. Kral LA, Jackson K, Uritsky T. A practical guide to tapering opioids. Ment Health Clin [Internet]. 2015;5(3):102-8. DOI: 10.9740/mhc.2015.05.102.. Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. FDA’s Role and . Emerging Challenges. Jeanne Ireland. Principal, Ireland Strategies, LLC. 2015 CWAG Annual Meeting. The Opioid Epidemic. Some progress being made, but devastating effects of epidemic continue. Bureau of Health Care Safety and Quality. Department of Public Health. December 15, 2016. Draft Formulary (105 CMR 720). Schedule. Amendments. Comments. Guidance. Interchangeable Abuse Deterrent Drug Products Evaluation. CONVERSION FACTOR them together. 3 2 each opioid by the conversion factor. ( dosed in mcg/hr instead of mg/day, and HOW SHOULD PROVIDERS USE THE TOTAL DAILY OPIOID DOSE IN CLINICAL PRACTICE? Us Psycho-Education for Patients and Family Members. 12-. 1. The Importance of Total Abstinence. Abstinence from all substances that affect the brain—even alcohol—greatly increases the chances of a successful recovery..
Download Document
Here is the link to download the presentation.
"Abuse Deterrent Opioids"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents